Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York, New York 10022
July 24, 2013
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Adam Turk, Esq.
Re: | Tonix Pharmaceuticals Holding Corp. |
Registration Statement on Form S-1
File No. 333-188547
Ladies and Gentlemen:
Tonix Pharmaceuticals Holding Corp. hereby respectfully requests the withdrawal of its request for acceleration dated July 22, 2013, of the effective date of the registration statement referred to above that was requested to become effective at 4:00 p.m., Washington D.C. time, on Wednesday, July 24, 2012, or as soon thereafter as practicable.
TONIX PHARMACEUTICALS HOLDING CORP. | ||
By: | /s/ SETH LEDERMAN | |
Name: Seth Lederman | ||
Title: Chief Executive Officer |